Knights of Columbus Asset Advisors LLC Acquires 1,411 Shares of Colgate-Palmolive Company $CL

Knights of Columbus Asset Advisors LLC grew its holdings in Colgate-Palmolive Company (NYSE:CL) by 3.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 42,196 shares of the company’s stock after buying an additional 1,411 shares during the period. Knights of Columbus Asset Advisors LLC’s holdings in Colgate-Palmolive were worth $3,836,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. Westend Capital Management LLC raised its position in shares of Colgate-Palmolive by 111.1% in the first quarter. Westend Capital Management LLC now owns 266 shares of the company’s stock valued at $25,000 after purchasing an additional 140 shares during the period. Cornerstone Planning Group LLC boosted its holdings in shares of Colgate-Palmolive by 1,913.3% during the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock worth $28,000 after buying an additional 287 shares during the period. Saudi Central Bank acquired a new position in Colgate-Palmolive in the 1st quarter valued at about $29,000. Ransom Advisory Ltd bought a new position in Colgate-Palmolive in the 1st quarter valued at about $33,000. Finally, Harel Insurance Investments & Financial Services Ltd. acquired a new stake in Colgate-Palmolive during the first quarter worth approximately $37,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Down 0.4%

CL stock opened at $78.01 on Monday. The stock has a market capitalization of $63.05 billion, a P/E ratio of 21.91, a price-to-earnings-growth ratio of 4.06 and a beta of 0.34. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The firm has a 50-day moving average price of $83.29 and a 200-day moving average price of $88.30. Colgate-Palmolive Company has a 12 month low of $77.91 and a 12 month high of $102.61.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The company had revenue of $5.11 billion during the quarter, compared to analysts’ expectations of $5.03 billion. During the same period in the prior year, the company earned $0.91 EPS. Colgate-Palmolive’s revenue was up 1.0% compared to the same quarter last year. As a group, equities research analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be paid a $0.52 dividend. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 annualized dividend and a dividend yield of 2.7%. Colgate-Palmolive’s payout ratio is currently 58.43%.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on CL. Weiss Ratings reiterated a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Saturday, September 27th. JPMorgan Chase & Co. lowered their price objective on Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating on the stock in a research report on Monday, August 4th. Wells Fargo & Company reduced their target price on shares of Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating for the company in a research report on Thursday, September 25th. Morgan Stanley lowered their price target on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a research report on Monday, August 4th. Finally, UBS Group cut their price objective on shares of Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating for the company in a report on Thursday, July 17th. Seven analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $94.83.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.